Binukumar, B., Shukla, V., Amin, N. D., Grant, P., Bhaskar, M., Skuntz, S., . . . Pant, H. C. (2015). Peptide TFP5/TP5 derived from Cdk5 activator P35 provides neuroprotection in the MPTP model of Parkinson’s disease. Mol Biol Cell.
Dyfyniad Arddull ChicagoBinukumar, BK., Varsha Shukla, Niranjana D. Amin, Philip Grant, M. Bhaskar, Susan Skuntz, Joseph Steiner, and Harish C. Pant. "Peptide TFP5/TP5 Derived From Cdk5 Activator P35 Provides Neuroprotection in the MPTP Model of Parkinson’s Disease." Mol Biol Cell 2015.
Dyfyniad MLABinukumar, BK., et al. "Peptide TFP5/TP5 Derived From Cdk5 Activator P35 Provides Neuroprotection in the MPTP Model of Parkinson’s Disease." Mol Biol Cell 2015.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.